Understanding Immunity in Children Vaccinated With Live Attenuated Influenza Vaccine

被引：12

作者：

Shannon, Ian ^{[1
]}

White, Chantelle L. ^{[2
]}

Nayak, Jennifer L. ^{[1
]}

机构：

[1] Univ Rochester, Med Ctr, Dept Pediat, Div Infect Dis, Rochester, NY 14642 USA

[2] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2020年 / 9卷

关键词：

immune protection; influenza; influenza vaccines; LAIV; T-CELL RESPONSES; HEMAGGLUTINATION-INHIBITION; SEASONAL INFLUENZA; UNITED-STATES; IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; B-CELL; VIRUS; PROTECTION; TRIVALENT;

D O I：

10.1093/jpids/piz083

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Live attenuated influenza vaccine (LAIV), or FluMist, was approved for use in the United States in 2003. This vaccine, administered intranasally, offers the advantage of stimulating immunity at the site of infection in the upper respiratory tract and, by mimicking natural infection, has the potential to elicit a multifaceted immune response. However, the development of immunity following LAIV administration requires viral replication, causing vaccine effectiveness to be impacted by both the replicative fitness of the attenuated viruses being administered and the degree of the host's preexisting immunity. In this review, we discuss the current state of knowledge regarding the mechanisms of protection elicited by LAIV in children, contrast this with immune protection that develops upon vaccination with inactivated influenza vaccines, and briefly discuss both the potential advantages as well as challenges offered by this vaccination platform.

引用

页码：S10 / S14

页数：5

共 50 条

[31] Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
Roy, Sreeja
Williams, Clare M.
Wijesundara, Danushka K.
Furuya, Yoichi
[J]. VACCINES, 2020, 8 (04)
[32] LIVE ATTENUATED INFLUENZA-VIRUS VACCINE
KESSLER, H
[J]. LANCET, 1980, 2 (8191): : 431 - 432
[33] Live, attenuated influenza vaccine demonstrated ineffective
Frank, Arthur
[J]. JOURNAL OF PEDIATRICS, 2018, 192 : 266 - 267
[34] Live Attenuated and Inactivated Influenza Vaccine Effectiveness
Chung, Jessie R.
Flannery, Brendan
Ambrose, Christopher S.
Begue, Rodolfo E.
Caspard, Herve
DeMarcus, Laurie
Fowlkes, Ashley L.
Kersellius, Geeta
Steffens, Andrea
Fry, Alicia M.
[J]. PEDIATRICS, 2019, 143 (02)
[35] HUMAN IMMUNIZATION WITH LIVE ATTENUATED INFLUENZA VACCINE
BOUDREAULT, A
PAVILANIS, V
[J]. CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1974, 65 (01): : 59 - 59
[36] Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season
McLean, Huong Q.
Caspard, Herve
Griffin, Marie R.
Poehling, Katherine A.
Gaglani, Manjusha
Belongia, Edward A.
Talbot, H. Keipp
Peters, Timothy R.
Murthy, Kempapura
Ambrose, Christopher S.
[J]. VACCINE, 2017, 35 (20) : 2685 - 2693
[37] PERSISTENCE OF IMMUNITY TO VARICELLA IN CHILDREN WITH LEUKEMIA IMMUNIZED WITH LIVE ATTENUATED VARICELLA VACCINE
GERSHON, AA
STEINBERG, SP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (14): : 892 - 897
[38] Revisiting live attenuated influenza vaccine efficacy among children in developing countries
Bagga, Sumedha
Krishnan, Anand
Dar, Lalit
[J]. VACCINE, 2023, 41 (05) : 1009 - 1017
[39] EFFICACY OF A SINGLE DOSE OF LIVE ATTENUATED INFLUENZA VACCINE IN PREVIOUSLY UNVACCINATED CHILDREN
Moren, S.
Ambrose, C.
[J]. ACTA PAEDIATRICA, 2009, 98 : 194 - 194
[40] Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity
Ambrose, Christopher S.
Wu, Xionghua
Caspard, Herve
Belshe, Robert B.
[J]. VACCINE, 2014, 32 (43) : 5546 - 5548

← 1 2 3 4 5 →